IP Library Patent Application 12718668
Patent Application
App. No. 12/718,668

METHODS OF DETECTING AND GENOTYPING ESCHERICHIA COLI O157:H7

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/718,668
Abstract

A method for detecting and genotyping Escherichia coli O157:H7 strains, including detecting nucleotides at single nucleotide polymorphism (SNP) loci, the identity of which nucleotides define SNP genotypes. A method for genotyping E. coli O157:H7 strains, including detecting thirty-two nucleotides at thirty-two single nucleotide polymorphism (SNP) loci, the identity of which nucleotides define thirty-six SNP genotypes. Multiplexed primer trios capable of detecting the nucleotides at E. coli SNP loci, and a kit including one or more primer trios.

Claims (83)

1 . A method for genotyping Escherichia coli O157:H7, comprising:

providing a sample of DNA from a possible E. coli O157:H7 infection;

detecting in the sample whether the identity of

the nucleotide at position 125 of SEQ ID NO. 11 is thymine (T) or guanine (G),

the nucleotide at position 648 of SEQ ID NO. 82 is T or cytosine (C),

the nucleotide at position 299 of SEQ ID NO. 47 is T or C,

the nucleotide at position 339 of SEQ ID NO. 15 is T or C,

the nucleotide at position 144 of SEQ ID NO. 67 is adenine (A) or G,

the nucleotide at position 417 of SEQ ID NO. 78 is T or C,

the nucleotide at position 3971 of SEQ ID NO. 52 is G or T,

the nucleotide at position 1186 of SEQ ID NO. 75 is C or G,

the nucleotide at position 2244 of SEQ ID NO. 81 is T or C,

the nucleotide at position 1151 of SEQ ID NO. 10 is T or C,

the nucleotide at position 1678 of SEQ ID NO. 16 is G or C,

the nucleotide at position 1545 of SEQ ID NO. 17 is G or A,

the nucleotide at position 311 of SEQ ID NO. 21 is G or A,

the nucleotide at position 1340 of SEQ ID NO. 48 is G or A,

the nucleotide at position 776 of SEQ ID NO. 35 is G or A,

the nucleotide at position 132 of SEQ ID NO. 57 is G or T,

the nucleotide at position 348 of SEQ ID NO. 46 is A or C,

the nucleotide at position 928 of SEQ ID NO. 20 is G or A,

the nucleotide at position 849 of SEQ ID NO. 36 is G or A,

the nucleotide at position 247 of SEQ ID NO. 79 is G or A,

the nucleotide at position 83 of SEQ ID NO. 1 is T or C,

the nucleotide at position 117 of SEQ ID NO. 6 is C or A,

the nucleotide at position 259 of SEQ ID NO. 22 is C or T,

the nucleotide at position 379 of SEQ ID NO. 18 is C or T,

the nucleotide at position 739 of SEQ ID NO. 4 is G or A,

the nucleotide at position 527 of SEQ ID NO. 47 is C or T,

the nucleotide at position 693 of SEQ ID NO. 74 is C or T,

the nucleotide at position 281 of SEQ ID NO. 11 is C or T,

the nucleotide at position 267 of SEQ ID NO. 57 is G or A,

the nucleotide at position 2707 of SEQ ID NO. 66 is C or A,

the nucleotide at position 354 of SEQ ID NO. 47 is C or A, and

the nucleotide at position 339 of SEQ ID NO. 70 is T or A; and

using the identities of these nucleotides to determine whether the possible E. coli O157:H7 has a single nucleotide polymorphism genotype (SG) of an E. coli O157:H7 that is defined by these nucleotides.

2 . The method of claim 1 , wherein the identity of

the nucleotide at position 125 of SEQ ID NO. 11 is G,

the nucleotide at position 648 of SEQ ID NO. 82 is C,

the nucleotide at position 299 of SEQ ID NO. 47 is C,

the nucleotide at position 339 of SEQ ID NO. 15 is C,

the nucleotide at position 144 of SEQ ID NO. 67 is G,

the nucleotide at position 417 of SEQ ID NO. 78 is C,

the nucleotide at position 3971 of SEQ ID NO. 52 is T,

the nucleotide at position 1186 of SEQ ID NO. 75 is G,

the nucleotide at position 2244 of SEQ ID NO. 81 is T,

the nucleotide at position 1151 of SEQ ID NO. 10 is C,

the nucleotide at position 1678 of SEQ ID NO. 16 is G,

the nucleotide at position 1545 of SEQ ID NO. 17 is G,

the nucleotide at position 311 of SEQ ID NO. 21 is G,

the nucleotide at position 1340 of SEQ ID NO. 48 is A,

the nucleotide at position 776 of SEQ ID NO. 35 is A,

the nucleotide at position 132 of SEQ ID NO. 57 is G,

the nucleotide at position 348 of SEQ ID NO. 46 is A,

the nucleotide at position 928 of SEQ ID NO. 20 is G,

the nucleotide at position 849 of SEQ ID NO. 36 is G,

the nucleotide at position 247 of SEQ ID NO. 79 is G,

the nucleotide at position 83 of SEQ ID NO. 1 is C,

the nucleotide at position 117 of SEQ ID NO. 6 is C,

the nucleotide at position 259 of SEQ ID NO. 22 is C or T,

the nucleotide at position 379 of SEQ ID NO. 18 is C or T,

the nucleotide at position 739 of SEQ ID NO. 4 is G or A,

the nucleotide at position 527 of SEQ ID NO. 47 is C or T,

the nucleotide at position 693 of SEQ ID NO. 74 is C or T,

the nucleotide at position 281 of SEQ ID NO. 11 is T,

the nucleotide at position 267 of SEQ ID NO. 57 is G,

the nucleotide at position 2707 of SEQ ID NO. 66 is C,

the nucleotide at position 354 of SEQ ID NO. 47 is C, and

the nucleotide at position 339 of SEQ ID NO. 70 is T; and

the possible E. coli O157:H7 is determined to have a SG of an E. coli O157:H7 clade associated with more severe disease.

3 . The method of claim 1 , wherein the SG determination identifies the genotype of E. coli O157:H7.

4 . The method of claim 1 , wherein the SG identifies the clade of E. coli O157:H7.

5 . The method of claim 1 , wherein the SG determination is used to diagnose infection by E. coli O157:H7.

6 . The method of claim 1 , wherein the sample is from a plant or animal.

7 . The method of claim 6 , wherein the sample is from an animal.

8 . The method of claim 7 , wherein the animal is a human.

9 . The method of claim 1 , wherein the detecting is by a real-time polymerase chain reaction (PCR) assay.

10 . The method of claim 9 , wherein at least one primer trio is used to detect the identity of a nucleotide in the PCR assay.

11 . The method of claim 10 , wherein the primer trio is selected from the group consisting of SEQ ID NOs. 83-382.

12 . The method of claim 1 , wherein the SG is one of thirty-nine SGs defined by these nucleotides.

13 . The method of claim 1 , wherein the SG is one of thirty-six SGs defined by these nucleotides.

14 . The method of claim 1 , wherein the SG is one of thirty-three SGs defined by these nucleotides.

15 . A kit comprising at least three primers selected from the group consisting of oligonucleotides identified by SEQ ID NOs. 83-382.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 6, 2013
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 031152/0452 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2010
From: WHITTAM, BETH M.; MANNING, SHANNON; ALLAND, DAVID; MOTIWALA, ALIFIYA
To: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY; UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 024931/0080 →
CONFIRMATORY LICENSE Recorded Apr 13, 2010
From: MICHIGAN STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024224/0162 →